eFFECTOR Therapeutics, Inc.
EFTR · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $41,838 | $31,212 | $37,061 | $39,717 |
| - Cash | $15,508 | $14,875 | $5,386 | $14,714 |
| + Debt | $20,248 | $20,545 | $20,476 | $20,410 |
| Enterprise Value | $46,578 | $36,882 | $52,151 | $45,413 |
| Revenue | $0 | $162 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$28 | $132 | -$26 | -$27 |
| % Margin | – | 81.5% | – | – |
| EBITDA | -$8,057 | -$8,342 | -$7,829 | -$7,615 |
| % Margin | – | -5,149.4% | – | – |
| Net Income | -$8,834 | -$9,129 | -$8,303 | -$8,364 |
| % Margin | – | -5,635.2% | – | – |
| EPS Diluted | -3.31 | -3.42 | -3.36 | -4.37 |
| % Growth | 3.2% | -1.8% | 23.1% | – |
| Operating Cash Flow | -$7,278 | -$5,566 | -$7,755 | -$8,592 |
| Capital Expenditures | $0 | -$54 | -$2 | -$28 |
| Free Cash Flow | -$7,278 | -$5,620 | -$7,757 | -$8,620 |